DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here

Market access is becoming a critical component of medtech strategy with the rise of value-based care, shifting customer dynamics, regulatory hurdles, and intense scrutiny on the costs and benefits of innovative technologies. Many companies struggle to navigate this complex and rapidly-evolving access environment.

Our data and experts guide you through challenging market access scenarios, so you can focus on delivering the best care to the right patients:

Stay ahead

of global regulatory and market dynamics impacting access

Reinforce your portfolio value

with compelling, data-driven evidence

Maximize access

with innovative pricing and contracting strategies

Increase confidence

in your access strategy with accurate data and experienced consultants

How we help


Evidence generation strategy

Secure brand access and uptake with compelling, differentiated evidence

  • Our comprehensive data sets, researchers and strategists enable you to build and maintain a data generation plan that effectively supports your value proposition
  • Systematic reviews, economic modeling, and HEOR
  • U.S. and European real-world evidence capabilities
  • Integrated methodologies to provide qualitative and quantitative proof relevant to stakeholder value drivers across geographies


Coverage and reimbursement

Accelerate revenue generation with a proactive reimbursement strategy

  • Payer mix identification based on analysis of patient demographics, site of service, and the overall market
  • Review of reimbursement landscape of analogue devices and technologies
  • Stakeholder interviews to identify which evidence and features will influence reimbursement decisions
  • On-going monitoring of healthcare legislations and regulations at national and local levels to pivot reimbursement strategy accordingly


Pricing and contracting

Set up favorable partnerships with innovative contracting strategies

  • Identification of key stakeholders who influence product purchasing
  • Review of current and future contracting approaches and competitor strategies
  • Prioritization of the contracting conditions that will drive successful partnerships in competitive markets
  • Expertise in emerging innovative strategies, including value-based contracting

How can we support your market access strategy?

Data and services

Our integrated data repository underpins all of our solutions

DRG Integrated Data Repository
  • Linking and integration capabilities for a comprehensive market view
  • Largest volume of patients and hospitals covered in the industry
  • Expansive coverage for geographies and insurance types
  • Fastest, freshest market data available


  • Visibility into 300+ million patients (over 3 years)
  • 2+ million healthcare providers
  • 98% of 750 U.S. payers, real-time insight into market changes
  • Submitted claims (837s) and remittance (835s)
  • Hospitals, physician offices, ASCs, pharmacies long-term care, and nursing

Purchase order data

  • 1,900 hospitals and ASCs
  • 3,000 U.S. manufacturers
  • 2+ million U.S. SKUs
  • SKUs mapped to device categories

Electronic health records

  • Visibility into 100+ million patients (over 3 years)
  • 90 million patients with overlapping EHRs and medical / pharmacy claims
  • Diagnoses, diagnostic tests, assessments, vaccines, vitals, Rx

Encounter level hospital device usage

  • U.S.: 6,800 hospitals, 2+ million providers
  • Complete hospital claims and ASC data coverage directly from CMS
  • Europe: 12,000 hospitals, 22 countries covered, facility-level data
  • Global: Research-driven understanding of volumes and brand usage

Healthcare provider affiliation directory

  • 6.5+ million affiliations
  • Affiliations among 3,200 health systems and 2+ million HCPs

On demand market overview

  • 50 countries
  • 12 therapeutic areas
  • 80 device markets

Full spectrum of commercialization intelligence solutions:

From data and insights to putting strategy in action


Learn more


  • Claims
  • Electronic health records
  • Epidemiology
  • Healthcare organization affiliation directory
  • Lives data

Custom analytics & advisory

Learn more

Custom analytics & advisory

  • Real-world evidence
  • Market research
  • Custom data analysis
  • HEOR
  • Advisory and consulting


Learn more


  • Topical e-learning modules and interactive overviews (i.e., Medicare)
  • Training workshops

Global coverage across 80+ device markets and 50+ countries

Why we're different

Data accuracy and diversity

Answering the sorts of complex market access questions that are increasingly important in medical device markets requires a rich, diverse data set.

To guide client decisions, we leverage chargemaster data, which lets us analyze device penetration and hospital charges; purchase order data, for assessing impact of brand rationalization and cross-portfolio selling; and multi-payer claims data, for understanding differences in reimbursement and economic outcomes by payer or region.

Adrienne Lovink

Partner, Medtech Consulting and Analytics

Decision Resources Group

Market access expertise

Our deep bench of seasoned analysts, consultants and data scientists brings a wealth of experience supporting successful market access strategies, from navigating the intricacies of regulatory dynamics to developing innovative contracting approaches.

We also field a dedicated team of U.S. and global access analysts tracking local regulatory updates, market dynamics, and policy changes so clients have the most up-to-date intelligence for fast-changing environments.

Zaid Al-Nassir

Regulatory Affairs, Medtech

Decision Resources Group

Collaborative partnerships

We pride ourselves on being a true partner to our clients, almost an extension of their own market access teams.

Whether the topic is evidence generation, coverage and reimbursement or value-based contracting, our dedicated service team will get you quick answers to your questions, and our experts are ready to help work through the thorny challenges.

Chris Leonard

Client Engagement Specialist

Decision Resources Group




What's Driving Value-Based Contracting in Medtech?

View now



The European MDR: Impetus, Impacts, And Current Status

View now


Blog post

CVS Health, Aetna’s Social Health Initiative Lays New Tracks

View now

Get started

Talk to us about your market access challenges

Related solutions

DRG data and experts support client decisions across the commercialization spectrum

Strategic Portfolio Planning

Launch Strategy

Commercial Effectiveness

Product Lifecycle Management

Medtech Overview